Effects of Liothyronine on Energy Expenditure and Cardiovascular Function
Sponsor: Virginia Commonwealth University
This PHASE1/PHASE2 trial investigates Healthy and is currently completed. Virginia Commonwealth University leads this study, which shows 13 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Apr 2021 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
Jan 2021 — Apr 2021 [monthly]
Completed PHASE1_PHASE2
-
Aug 2020 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
▶ Show 8 earlier versions
-
May 2020 — Aug 2020 [monthly]
Completed PHASE1_PHASE2
-
Apr 2020 — May 2020 [monthly]
Completed PHASE1_PHASE2
Status: Recruiting → Completed
-
Jul 2019 — Apr 2020 [monthly]
Recruiting PHASE1_PHASE2
-
Aug 2018 — Jul 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE1_PHASE2
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
Status: Not Yet Recruiting → Recruiting
-
May 2017 — May 2018 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Apr 2017 — May 2017 [monthly]
Not Yet Recruiting PHASE1_PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Virginia Commonwealth University
For direct contact, visit the study record on ClinicalTrials.gov .